|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/4745 | (2006.01) |
| A61K 31/12 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/7068 | (2006.01) | ||
| A61K 31/704 | (2006.01) | ||
| A61K 31/555 | (2006.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61K 31/495 | (2006.01) | ||
| A61K 31/475 | (2006.01) | ||
| A61K 31/4045 | (2006.01) | ||
| A61K 31/337 | (2006.01) | ||
| A61K 31/282 | (2006.01) | ||
| A61K 31/19 | (2006.01) | ||
| A61K 31/135 | (2006.01) | ||
| A61K 31/167 | (2006.01) | ||
| A61K 31/404 | (2006.01) | ||
| A61K 31/4545 | (2006.01) | ||
| A61K 31/52 | (2006.01) | ||
| A61K 31/496 | (2006.01) | ||
| A61P 35/02 | (2006.01) |
| (11) | Number of the document | 3429571 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17710261.3 |
| Date of filing the European patent application | 2017-03-13 | |
| (97) | Date of publication of the European application | 2019-01-23 |
| (45) | Date of publication and mention of the grant of the patent | 2025-10-08 |
| (46) | Date of publication of the claims translation | 2026-01-26 |
| (86) | Number | PCT/EP2017/055784 |
| Date | 2017-03-13 |
| (87) | Number | WO 2017/157825 |
| Date | 2017-09-21 |
| (30) | Number | Date | Country code |
| 201662308529 P | 2016-03-15 | US |
| (72) |
DEMARIO, Mark , US
PIERCEALL, William , US
MACK, Fiona , US
MAES, Tamara , ES
LUNARDI, Serena , ES
|
| (73) |
Oryzon Genomics, S.A. ,
Carrera de San Jérónimo 15
2nd floor, 28014 Madrid,
ES
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | SD1 inhibitorių deriniai, skirti neoplastinių ligų gydymui |
| COMBINATIONS OF LSD1 INHIBITORS FOR USE IN THE TREATMENT OF NEOPLASTIC DISEASES |
| Payment date | Validity (years) | Amount | |
| 2026-03-06 | 10 | 231.00 EUR |
| 2027-03-13 |